The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Long-acting Hormone Injection Market Research Report 2025
Synopsis
The global Long-acting Hormone Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Long-acting Hormone Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long-acting Hormone Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Long-acting Hormone Injection include Pfizer, Bayer, Organon, Merck & Co. Inc., Adare Pharma Solutions, Mylan NV, Novo Nordisk, Genentech, Eli Lily, Shree Venkatesh International Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Long-acting Hormone Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Hormone Injection.
The Long-acting Hormone Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-acting Hormone Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting Hormone Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Bayer
Organon
Merck & Co. Inc.
Adare Pharma Solutions
Mylan NV
Novo Nordisk
Genentech
Eli Lily
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical
Segment by Type
Long-acting Contraceptive Injection
Growth Hormone Injection
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-acting Hormone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-acting Hormone Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Long-acting Hormone Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Long-acting Hormone Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long-acting Hormone Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Long-acting Hormone Injection include Pfizer, Bayer, Organon, Merck & Co. Inc., Adare Pharma Solutions, Mylan NV, Novo Nordisk, Genentech, Eli Lily, Shree Venkatesh International Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Long-acting Hormone Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Hormone Injection.
The Long-acting Hormone Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-acting Hormone Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting Hormone Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Bayer
Organon
Merck & Co. Inc.
Adare Pharma Solutions
Mylan NV
Novo Nordisk
Genentech
Eli Lily
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical
Segment by Type
Long-acting Contraceptive Injection
Growth Hormone Injection
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-acting Hormone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-acting Hormone Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Long-acting Hormone Injection Market Overview
1.1 Product Definition
1.2 Long-acting Hormone Injection by Type
1.2.1 Global Long-acting Hormone Injection Market Value Comparison by Type (2024-2030)
1.2.2 Long-acting Contraceptive Injection
1.2.3 Growth Hormone Injection
1.2.4 Others
1.3 Long-acting Hormone Injection by Application
1.3.1 Global Long-acting Hormone Injection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Long-acting Hormone Injection Market Size Estimates and Forecasts
1.4.1 Global Long-acting Hormone Injection Revenue 2019-2030
1.4.2 Global Long-acting Hormone Injection Sales 2019-2030
1.4.3 Global Long-acting Hormone Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Long-acting Hormone Injection Market Competition by Manufacturers
2.1 Global Long-acting Hormone Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Long-acting Hormone Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Long-acting Hormone Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Long-acting Hormone Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting Hormone Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting Hormone Injection, Product Type & Application
2.7 Global Key Manufacturers of Long-acting Hormone Injection, Date of Enter into This Industry
2.8 Global Long-acting Hormone Injection Market Competitive Situation and Trends
2.8.1 Global Long-acting Hormone Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting Hormone Injection Players Market Share by Revenue
2.8.3 Global Long-acting Hormone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Hormone Injection Market Scenario by Region
3.1 Global Long-acting Hormone Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Long-acting Hormone Injection Sales by Region: 2019-2030
3.2.1 Global Long-acting Hormone Injection Sales by Region: 2019-2024
3.2.2 Global Long-acting Hormone Injection Sales by Region: 2025-2030
3.3 Global Long-acting Hormone Injection Revenue by Region: 2019-2030
3.3.1 Global Long-acting Hormone Injection Revenue by Region: 2019-2024
3.3.2 Global Long-acting Hormone Injection Revenue by Region: 2025-2030
3.4 North America Long-acting Hormone Injection Market Facts & Figures by Country
3.4.1 North America Long-acting Hormone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Long-acting Hormone Injection Sales by Country (2019-2030)
3.4.3 North America Long-acting Hormone Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting Hormone Injection Market Facts & Figures by Country
3.5.1 Europe Long-acting Hormone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Long-acting Hormone Injection Sales by Country (2019-2030)
3.5.3 Europe Long-acting Hormone Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Hormone Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Hormone Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Long-acting Hormone Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Long-acting Hormone Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting Hormone Injection Market Facts & Figures by Country
3.7.1 Latin America Long-acting Hormone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Long-acting Hormone Injection Sales by Country (2019-2030)
3.7.3 Latin America Long-acting Hormone Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting Hormone Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Hormone Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Long-acting Hormone Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Long-acting Hormone Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting Hormone Injection Sales by Type (2019-2030)
4.1.1 Global Long-acting Hormone Injection Sales by Type (2019-2024)
4.1.2 Global Long-acting Hormone Injection Sales by Type (2025-2030)
4.1.3 Global Long-acting Hormone Injection Sales Market Share by Type (2019-2030)
4.2 Global Long-acting Hormone Injection Revenue by Type (2019-2030)
4.2.1 Global Long-acting Hormone Injection Revenue by Type (2019-2024)
4.2.2 Global Long-acting Hormone Injection Revenue by Type (2025-2030)
4.2.3 Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2030)
4.3 Global Long-acting Hormone Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Long-acting Hormone Injection Sales by Application (2019-2030)
5.1.1 Global Long-acting Hormone Injection Sales by Application (2019-2024)
5.1.2 Global Long-acting Hormone Injection Sales by Application (2025-2030)
5.1.3 Global Long-acting Hormone Injection Sales Market Share by Application (2019-2030)
5.2 Global Long-acting Hormone Injection Revenue by Application (2019-2030)
5.2.1 Global Long-acting Hormone Injection Revenue by Application (2019-2024)
5.2.2 Global Long-acting Hormone Injection Revenue by Application (2025-2030)
5.2.3 Global Long-acting Hormone Injection Revenue Market Share by Application (2019-2030)
5.3 Global Long-acting Hormone Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Long-acting Hormone Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Long-acting Hormone Injection Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Organon
6.3.1 Organon Company Information
6.3.2 Organon Description and Business Overview
6.3.3 Organon Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Organon Long-acting Hormone Injection Product Portfolio
6.3.5 Organon Recent Developments/Updates
6.4 Merck & Co. Inc.
6.4.1 Merck & Co. Inc. Company Information
6.4.2 Merck & Co. Inc. Description and Business Overview
6.4.3 Merck & Co. Inc. Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co. Inc. Long-acting Hormone Injection Product Portfolio
6.4.5 Merck & Co. Inc. Recent Developments/Updates
6.5 Adare Pharma Solutions
6.5.1 Adare Pharma Solutions Company Information
6.5.2 Adare Pharma Solutions Description and Business Overview
6.5.3 Adare Pharma Solutions Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Adare Pharma Solutions Long-acting Hormone Injection Product Portfolio
6.5.5 Adare Pharma Solutions Recent Developments/Updates
6.6 Mylan NV
6.6.1 Mylan NV Company Information
6.6.2 Mylan NV Description and Business Overview
6.6.3 Mylan NV Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan NV Long-acting Hormone Injection Product Portfolio
6.6.5 Mylan NV Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Novo Nordisk Long-acting Hormone Injection Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Company Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genentech Long-acting Hormone Injection Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 Eli Lily
6.9.1 Eli Lily Company Information
6.9.2 Eli Lily Description and Business Overview
6.9.3 Eli Lily Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lily Long-acting Hormone Injection Product Portfolio
6.9.5 Eli Lily Recent Developments/Updates
6.10 Shree Venkatesh International Limited
6.10.1 Shree Venkatesh International Limited Company Information
6.10.2 Shree Venkatesh International Limited Description and Business Overview
6.10.3 Shree Venkatesh International Limited Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolio
6.10.5 Shree Venkatesh International Limited Recent Developments/Updates
6.11 LG Chem
6.11.1 LG Chem Company Information
6.11.2 LG Chem Description and Business Overview
6.11.3 LG Chem Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LG Chem Long-acting Hormone Injection Product Portfolio
6.11.5 LG Chem Recent Developments/Updates
6.12 Anhui Anke Biotechnology
6.12.1 Anhui Anke Biotechnology Company Information
6.12.2 Anhui Anke Biotechnology Description and Business Overview
6.12.3 Anhui Anke Biotechnology Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolio
6.12.5 Anhui Anke Biotechnology Recent Developments/Updates
6.13 Zhongshan Sinobioway Hygene Biomedicine
6.13.1 Zhongshan Sinobioway Hygene Biomedicine Company Information
6.13.2 Zhongshan Sinobioway Hygene Biomedicine Description and Business Overview
6.13.3 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolio
6.13.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments/Updates
6.14 Shanghai United Cell Biotechnology
6.14.1 Shanghai United Cell Biotechnology Company Information
6.14.2 Shanghai United Cell Biotechnology Description and Business Overview
6.14.3 Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolio
6.14.5 Shanghai United Cell Biotechnology Recent Developments/Updates
6.15 Changchun GeneScience Pharmaceutical
6.15.1 Changchun GeneScience Pharmaceutical Company Information
6.15.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.15.3 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolio
6.15.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Hormone Injection Industry Chain Analysis
7.2 Long-acting Hormone Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Hormone Injection Production Mode & Process
7.4 Long-acting Hormone Injection Sales and Marketing
7.4.1 Long-acting Hormone Injection Sales Channels
7.4.2 Long-acting Hormone Injection Distributors
7.5 Long-acting Hormone Injection Customers
8 Long-acting Hormone Injection Market Dynamics
8.1 Long-acting Hormone Injection Industry Trends
8.2 Long-acting Hormone Injection Market Drivers
8.3 Long-acting Hormone Injection Market Challenges
8.4 Long-acting Hormone Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Long-acting Hormone Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Long-acting Hormone Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Long-acting Hormone Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Long-acting Hormone Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Long-acting Hormone Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Long-acting Hormone Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Long-acting Hormone Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Long-acting Hormone Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Long-acting Hormone Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Long-acting Hormone Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Long-acting Hormone Injection, Product Type & Application
Table 12. Global Key Manufacturers of Long-acting Hormone Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting Hormone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Hormone Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting Hormone Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Long-acting Hormone Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Long-acting Hormone Injection Sales Market Share by Region (2019-2024)
Table 19. Global Long-acting Hormone Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Long-acting Hormone Injection Sales Market Share by Region (2025-2030)
Table 21. Global Long-acting Hormone Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Long-acting Hormone Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Long-acting Hormone Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Long-acting Hormone Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Long-acting Hormone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Long-acting Hormone Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Long-acting Hormone Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Long-acting Hormone Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Long-acting Hormone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Long-acting Hormone Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Long-acting Hormone Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Long-acting Hormone Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Long-acting Hormone Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Long-acting Hormone Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Long-acting Hormone Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Long-acting Hormone Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Long-acting Hormone Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Long-acting Hormone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Long-acting Hormone Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Long-acting Hormone Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Long-acting Hormone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Long-acting Hormone Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Long-acting Hormone Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Long-acting Hormone Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Long-acting Hormone Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Long-acting Hormone Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Table 53. Global Long-acting Hormone Injection Sales Market Share by Type (2025-2030)
Table 54. Global Long-acting Hormone Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Long-acting Hormone Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Long-acting Hormone Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Long-acting Hormone Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Long-acting Hormone Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Long-acting Hormone Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Long-acting Hormone Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Table 63. Global Long-acting Hormone Injection Sales Market Share by Application (2025-2030)
Table 64. Global Long-acting Hormone Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Long-acting Hormone Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Long-acting Hormone Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Long-acting Hormone Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Long-acting Hormone Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Long-acting Hormone Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Long-acting Hormone Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Long-acting Hormone Injection Product
Table 79. Bayer Recent Developments/Updates
Table 80. Organon Company Information
Table 81. Organon Description and Business Overview
Table 82. Organon Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Organon Long-acting Hormone Injection Product
Table 84. Organon Recent Developments/Updates
Table 85. Merck & Co. Inc. Company Information
Table 86. Merck & Co. Inc. Description and Business Overview
Table 87. Merck & Co. Inc. Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck & Co. Inc. Long-acting Hormone Injection Product
Table 89. Merck & Co. Inc. Recent Developments/Updates
Table 90. Adare Pharma Solutions Company Information
Table 91. Adare Pharma Solutions Description and Business Overview
Table 92. Adare Pharma Solutions Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Adare Pharma Solutions Long-acting Hormone Injection Product
Table 94. Adare Pharma Solutions Recent Developments/Updates
Table 95. Mylan NV Company Information
Table 96. Mylan NV Description and Business Overview
Table 97. Mylan NV Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Mylan NV Long-acting Hormone Injection Product
Table 99. Mylan NV Recent Developments/Updates
Table 100. Novo Nordisk Company Information
Table 101. Novo Nordisk Description and Business Overview
Table 102. Novo Nordisk Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novo Nordisk Long-acting Hormone Injection Product
Table 104. Novo Nordisk Recent Developments/Updates
Table 105. Genentech Company Information
Table 106. Genentech Description and Business Overview
Table 107. Genentech Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Genentech Long-acting Hormone Injection Product
Table 109. Genentech Recent Developments/Updates
Table 110. Eli Lily Company Information
Table 111. Eli Lily Description and Business Overview
Table 112. Eli Lily Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Eli Lily Long-acting Hormone Injection Product
Table 114. Eli Lily Recent Developments/Updates
Table 115. Shree Venkatesh International Limited Company Information
Table 116. Shree Venkatesh International Limited Description and Business Overview
Table 117. Shree Venkatesh International Limited Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shree Venkatesh International Limited Long-acting Hormone Injection Product
Table 119. Shree Venkatesh International Limited Recent Developments/Updates
Table 120. LG Chem Company Information
Table 121. LG Chem Description and Business Overview
Table 122. LG Chem Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. LG Chem Long-acting Hormone Injection Product
Table 124. LG Chem Recent Developments/Updates
Table 125. Anhui Anke Biotechnology Company Information
Table 126. Anhui Anke Biotechnology Description and Business Overview
Table 127. Anhui Anke Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Anhui Anke Biotechnology Long-acting Hormone Injection Product
Table 129. Anhui Anke Biotechnology Recent Developments/Updates
Table 130. Zhongshan Sinobioway Hygene Biomedicine Company Information
Table 131. Zhongshan Sinobioway Hygene Biomedicine Description and Business Overview
Table 132. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product
Table 134. Zhongshan Sinobioway Hygene Biomedicine Recent Developments/Updates
Table 135. Shanghai United Cell Biotechnology Company Information
Table 136. Shanghai United Cell Biotechnology Description and Business Overview
Table 137. Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Shanghai United Cell Biotechnology Long-acting Hormone Injection Product
Table 139. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 140. Changchun GeneScience Pharmaceutical Company Information
Table 141. Changchun GeneScience Pharmaceutical Description and Business Overview
Table 142. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product
Table 144. Changchun GeneScience Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Long-acting Hormone Injection Distributors List
Table 148. Long-acting Hormone Injection Customers List
Table 149. Long-acting Hormone Injection Market Trends
Table 150. Long-acting Hormone Injection Market Drivers
Table 151. Long-acting Hormone Injection Market Challenges
Table 152. Long-acting Hormone Injection Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-acting Hormone Injection
Figure 2. Global Long-acting Hormone Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Long-acting Hormone Injection Market Share by Type: 2023 & 2030
Figure 4. Long-acting Contraceptive Injection Product Picture
Figure 5. Growth Hormone Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global Long-acting Hormone Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Long-acting Hormone Injection Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Long-acting Hormone Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Long-acting Hormone Injection Market Size (2019-2030) & (US$ Million)
Figure 14. Global Long-acting Hormone Injection Sales (2019-2030) & (K Units)
Figure 15. Global Long-acting Hormone Injection Average Price (US$/Unit) & (2019-2030)
Figure 16. Long-acting Hormone Injection Report Years Considered
Figure 17. Long-acting Hormone Injection Sales Share by Manufacturers in 2023
Figure 18. Global Long-acting Hormone Injection Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Long-acting Hormone Injection Players: Market Share by Revenue in Long-acting Hormone Injection in 2023
Figure 20. Long-acting Hormone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Long-acting Hormone Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Long-acting Hormone Injection Sales Market Share by Country (2019-2030)
Figure 23. North America Long-acting Hormone Injection Revenue Market Share by Country (2019-2030)
Figure 24. United States Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Long-acting Hormone Injection Sales Market Share by Country (2019-2030)
Figure 27. Europe Long-acting Hormone Injection Revenue Market Share by Country (2019-2030)
Figure 28. Germany Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Long-acting Hormone Injection Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Long-acting Hormone Injection Revenue Market Share by Region (2019-2030)
Figure 35. China Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Long-acting Hormone Injection Sales Market Share by Country (2019-2030)
Figure 43. Mexico Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Long-acting Hormone Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Long-acting Hormone Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Long-acting Hormone Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Long-acting Hormone Injection by Type (2019-2030)
Figure 53. Global Revenue Market Share of Long-acting Hormone Injection by Type (2019-2030)
Figure 54. Global Long-acting Hormone Injection Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Long-acting Hormone Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Long-acting Hormone Injection by Application (2019-2030)
Figure 57. Global Long-acting Hormone Injection Price (US$/Unit) by Application (2019-2030)
Figure 58. Long-acting Hormone Injection Value Chain
Figure 59. Long-acting Hormone Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
